Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if BFRI is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
6 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 6
19 filers reported a long position in BFRI for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Rosalind Advisors, Inc. | $1.2M | 1.3M | +9.6% |
| AIGH Capital Management LLC | $699.6K | 739.9K | -19.2% |
| RENAISSANCE TECHNOLOGIES LLC | $148.9K | 157.5K | New |
| CITADEL ADVISORS LLC | $99.2K | 104.9K | New |
| JANE STREET GROUP, LLC | $87.9K | 93K | New |
| GEODE CAPITAL MANAGEMENT, LLC | $72.5K | 76.7K | -29.8% |
| VANGUARD CAPITAL MANAGEMENT LLC | $67.5K | 71.4K | +36.6% |
| VANGUARD FIDUCIARY TRUST CO | $58.4K | 61.7K | Unchanged |
| XTX Topco Ltd | $49.1K | 51.9K | +130.7% |
| HRT FINANCIAL LP | $40K | 43.3K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.